Two prototype vaccines tested on lab mice "provided complete protection against the Zika virus" with just a single shot, reported the first team.
"These findings certainly raise optimism that the development of a safe and effective vaccine against Zika virus for humans may be successful," said Dan Barouch, director of the Harvard Medical School's Center for Virology and Vaccine Research, who co-authored a paper in Nature.
His optimism was echoed in a separate study into Zika infection in rhesus macaques -- close genetic relatives of humans and well-matched animal models for medical testing.
And they found that a single infection, mostly symptom-free as in humans, provided "complete protection" against later Zika exposure.
"This is a key finding because it means that a vaccine could be quite effective against the virus," said study co-author Dawn Dudley of the University of Wisconsin-Madison.
"It also indicates that people who are already infected with Zika virus are not susceptible to future infection, for example during a future pregnancy."
Benign in most people, Zika has been linked to a form of severe brain damage called microcephaly in babies, and to rare adult-onset neurological problems such as Guillain-Barre Syndrome, which can result in paralysis and death.
On the downside, Dudley's team found that the virus persisted as much as two months longer in pregnant monkeys as non-pregnant ones, who were generally virus-free within 10 days after infection.
One hypothesis was that the foetuses themselves are infected, and remain so for much longer than adults.
"(M)y concern for Zika virus in pregnancy is much higher now than it was six months ago," Dudley said of the discovery.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
